User:DHayes14/sandbox

Summary of the Five Pillars

 * 1) Wikipedia is an Encyclopedia .  It is a living reference work that includes articles and entries.
 * 2) Wikipedia is written from a neutral point of view.  Be mindful to choose words that are not biased.
 * 3) Wikipedia is free content that anyone can edit, use, modify, and distribute. You do not own your article and anyone can feel free to edit it.
 * 4) Editors should treat each other with respect and civility.  Be respectful to your fellow Wikipedians!
 * 5) Wikipedia does not have firm rules.  When contributing, do what you think is sensible, in a thoughtful and polite way.

Summary of characteristics of target article

 * 1) Article is professional, well-researched, and a source for encyclopedic information.
 * 2) Attention should be paid to content and style, and in compliance with the Manual of Style. Tone should be neutral.
 * 3) Take advantage of peer review process and incorporate suggestions as needed.
 * 4) Article may include supporting materials, such as media, pictures and graphs.
 * 5) Inline citations from reliable sources are used whenever necessary.
 * 6) The article should be well organized, clear and concise and as complete as possible.

Students will choose an article that has a "stub" classification. Goal for quality level for this project is between a B and a GA.

Yoga for Breast Cancer Survivors
Although it is not a cure for cancer, yoga may be a practice that enhances mood and reduces inflammation and fatigue in breast cancer survivors. Yoga, meaning to yoke or join the mind and body, is a physical, mental, and spiritual practice that has existed since 500-200BCE. It is thought that a yoga practice that is tailored to individuals who have functional limitations may be beneficial and was therefore appealing to researchers at Ohio State University. In a randomized controlled 3-month trial, 200 breast cancer survivors were assigned to either a 90-minute yoga class for two times a week, or a wait-list group. Results of this study indicated that those participants assigned to the yoga group experienced greater vitality, but no less fatigue, than the wait-list group. The impact of more frequent yoga classes showed larger changes in decreased fatigue and increased vitality, as well as decreased proinflammatory cytokines including IL-6, TNF-α, and IL-1β.

A systematic review and meta-analysis of yoga for breast cancer survivors was completed in 2012 by the Chair of the Complementary and Integrative Medicine at the University of Duisburg-Essen in Essen, Germany. This review of 12 randomized clinical trials showed positive short-term effects on quality of life, in addition to spiritual, functional and social well-being. As depression and anxiety are quite commonly experienced in breast cancer patients and survivors, yoga may be one possible recommendation for the improvement psychological health.

Preliminary Outline for Polysomy Article
1. Polysomy Definition 2. Polysomy Types 2.1 trisomy (links to wiki page) 2.2 tetrasomy (links to wiki page) 2.2a quadrosomy 2.2b quatrosomy 2.3 pentasomy 2.4 heptasomy 2.5 hexasomy 2.6 octosomy 2.7 nanosomy 2.8 decasomy 3. Polysomy in Animals 3.1 Polysomy 13 in Canines 3.2 Germ line polysomy in the grasshopper 3.3 Heterochromatic polysomy in the cricket 3.4 X-chromosome polysomy in Drosphilia 3.5 Polysomy in humans 3.5a Polysomy X (both male and female) 3.5b Polysomy Y		   3.5c Polysomy of chromosome 7 3.5d Polysomy of chromosome 8 3.5e Polysomy of chromosome 17 3.5f Trisomy 21 3.5g Quadrosomy 4 & Quatrosomy 13 3.5h Tetrasomy 9 3.5i Tetrasomy 18 4. Polysomy in Plants 4.1 Ornithogalum umbellatum L. (Liliaceae) 4.2 Ophioglossum reticulatum 4.3 Conifers 5. Polysomy in Fungi 5.1 Saccharomyces cerevisiae 6. Terminology 6.1 Aneuploidy 6.2 Polyploidy 6.3 Karyotype 6.4 Paralogous 6.5 Homologous 7. See Also 8. References 9. Further Reading 10. Links

Unit 5 Reference List

 * 1) Adds, J., Larkcom, E., & Miller, R. (2001). Genetics, evolution, and biodiversity. (p. 93). Chettenham, United Kingdom: Nelson Thomas Ltd. Retrieved from http://books.google.com/books?id=U3RN9tKstLMC&pg=PA95&lpg=PA95&dq=examples of polysomy&source=bl&ots=hnPWcB6C4G&sig=ck0Pbt9y_wcC61NThBwenJ69k5U&hl=en&sa=X&ei=HeYMU8bgDbSqsQT-4IHwCA&ved=0CC0Q6AEwAjgK
 * 2) Celik, A; Eraslan, S; Gökgöz, N; Ilgin, H; Başaran, S; Bökesoy, I; Kayserili, H; Yüksel-Apak, M; Kirdar, B (1997 Jun). "Identification of the parental origin of polysomy in two 49,XXXXY cases.". Clinical genetics 51 (6): 426–9..
 * 3) Elias, S, Shulman, L, Glob. libr. women's med.,(ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.10358. http://www.glowm.com/section_view/heading/Males%20with%20Polysomy%20Y%20and%20Females%20with%20Polysomy%20X/item/357
 * 4) Leal, C. A., et al. "Parental origin of the extra chromosomes in polysomy X." Human genetics 94.4 (1994): 423-426. Available at http://link.springer.com/article/10.1007/BF00201605#page-1
 * 5) "Polysomy". Retrieved 23 February 2014.<http://medical-dictionary.thefreedictionary.com/polysomy
 * Ma, Yan, et al. "Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practice." Clinical cancer research 11.12 (2005): 4393-4399. Available at http://clincancerres.aacrjournals.org/content/11/12/4393.short
 * 1) Miller, John Adds, Erica Larkcom, Ruth (2004). Genetics, evolution and biodiversity (Rev. ed. ed.). Cheltenham: Nelson Thornes. ISBN 9780748774920.http://books.google.com/books?
 * Qu, L., and J. F. Hancock. "Detecting and mapping repulsion-phase linkage in polyploids with polysomic inheritance." Theoretical and Applied Genetics 103.1 (2001): 136-143 Available at Qu, L., and J. F. Hancock. "Detecting and mapping repulsion-phase linkage in polyploids with polysomic inheritance." Theoretical and Applied Genetics 103.1 (2001): 136-143. Available at http://link.springer.com/article/10.1007%2Fs001220100647?LI=true#page-1
 * 1) "Is polysomy 17 an important phenomenon to predict treatment with trastuzumab in breast cancer?". Retrieved 23 February 2014. http://www.appliedcr.org.br/detalhe_artigo.asp?id=226
 * Yeh, I., Martin, M., Robetorye, R., Bolla, A., McCaskill, C., Shah, P., Gorre, M., & Mohammed, M. (2009). Clinical validation of an array cgh test for her2 status in breast cancer reveals that polysomy 17 is a rare event. Modern Pathology, 22, 1169-1175. doi: 10.1038/modpathol.2009.78

Unit 7 Reference List

 * 1) Adds, J., Larkcom, E., & Miller, R. (2001). Genetics, evolution, and biodiversity. (p. 93). Chettenham, United Kingdom: Nelson Thomas Ltd. Retrieved from http://books.google.com/books?id=U3RN9tKstLMC&pg=PA95&lpg=PA95&dq=examples of polysomy&source=bl&ots=hnPWcB6C4G&sig=ck0Pbt9y_wcC61NThBwenJ69k5U&hl=en&sa=X&ei=HeYMU8bgDbSqsQT-4IHwCA&ved=0CC0Q6AEwAjgK
 * 2) Celik, A; Eraslan, S; Gökgöz, N; Ilgin, H; Başaran, S; Bökesoy, I; Kayserili, H; Yüksel-Apak, M; Kirdar, B (1997 Jun). "Identification of the parental origin of polysomy in two 49,XXXXY cases.". Clinical genetics 51 (6): 426–9..
 * 3) Elias, S, Shulman, L, Glob. libr. women's med.,(ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.10358. http://www.glowm.com/section_view/heading/Males%20with%20Polysomy%20Y%20and%20Females%20with%20Polysomy%20X/item/357
 * 4) Kushnir, Tuviah. "Heterochromatic polysomy inGryllotalpa gryllotalpa L." Journal of Genetics 50.3 (1952): 361-383.
 * 5) Leal, C. A., et al. "Parental origin of the extra chromosomes in polysomy X." Human genetics 94.4 (1994): 423-426. Available at http://link.springer.com/article/10.1007/BF00201605#page-1
 * 6) "Polysomy". Retrieved 23 February 2014.<http://medical-dictionary.thefreedictionary.com/polysomy
 * Ma, Yan, et al. "Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practice." Clinical cancer research 11.12 (2005): 4393-4399. Available at http://clincancerres.aacrjournals.org/content/11/12/4393.short
 * 1) Miller, John Adds, Erica Larkcom, Ruth (2004). Genetics, evolution and biodiversity (Rev. ed. ed.). Cheltenham: Nelson Thornes. ISBN 9780748774920.http://books.google.com/books?
 * 2) Mossafa, H., et al. "Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis." Leukemia & lymphoma 47.9 (2006): 1885-1893.
 * Qu, L., and J. F. Hancock. "Detecting and mapping repulsion-phase linkage in polyploids with polysomic inheritance." Theoretical and Applied Genetics 103.1 (2001): 136-143 Available at Qu, L., and J. F. Hancock. "Detecting and mapping repulsion-phase linkage in polyploids with polysomic inheritance." Theoretical and Applied Genetics 103.1 (2001): 136-143. Available at http://link.springer.com/article/10.1007%2Fs001220100647?LI=true#page-1
 * 1) Reimann-Berg, N., et al. "Two new cases of polysomy 13 in canine prostate cancer." Cytogenetic and genome research 132.1-2 (2010): 16-21.
 * 2) "Is polysomy 17 an important phenomenon to predict treatment with trastuzumab in breast cancer?". Retrieved 23 February 2014. http://www.appliedcr.org.br/detalhe_artigo.asp?id=226
 * Yeh, I., Martin, M., Robetorye, R., Bolla, A., McCaskill, C., Shah, P., Gorre, M., & Mohammed, M. (2009). Clinical validation of an array cgh test for her2 status in breast cancer reveals that polysomy 17 is a rare event. Modern Pathology, 22, 1169-1175. doi: 10.1038/modpathol.2009.78

Brief Explanations for the List of References

 * 1) Adds, J., Larkcom, E., & Miller, R. (2001). Genetics, evolution, and biodiversity. (p. 93). Chettenham, United Kingdom: Nelson Thomas Ltd. Retrieved fromhttp://books.google.com/books?id=U3RN9tKstLMC&pg=PA95&lpg=PA95&dq=examples of polysomy&source=bl&ots=hnPWcB6C4G&sig=ck0Pbt9y_wcC61NThBwenJ69k5U&hl=en&sa=X&ei=HeYMU8bgDbSqsQT-4IHwCA&ved=0CC0Q6AEwAjgK Includes definition of polysomy and also distinguishes differences between polysomy and polyploidy.
 * 2) Celik, A; Eraslan, S; Gökgöz, N; Ilgin, H; Başaran, S; Bökesoy, I; Kayserili, H; Yüksel-Apak, M; Kirdar, B (1997 Jun). "Identification of the parental origin of polysomy in two 49,XXXXY cases.". Clinical genetics 51 (6): 426–9. .Data provide additional evidence of an identical mechanism of successive nondisjunctions in maternal meiosis I and II.
 * 3) Elias, S, Shulman, L, Glob. libr. women's med.,(ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.10358.http://www.glowm.com/section_view/heading/Males%20with%20Polysomy%20Y%20and%20Females%20with%20Polysomy%20X/item/357 Epidemiologic data and clinical features of polysomy X and polysomy Y are reviewed as well as recommendations for counseling both affected individuals and women carrying affected fetuses.
 * 4) Kushnir, Tuviah. "Heterochromatic polysomy inGryllotalpa gryllotalpa L." Journal of Genetics 50.3 (1952): 361-383. This article is about the evolution of the variations in chromosome number in the mole-cricket from the eastern Mediteranian. Heterochromatic refers to the dense/easily stained part of the chromosome.
 * 5) Leal, C. A., et al. "Parental origin of the extra chromosomes in polysomy X." Human genetics 94.4 (1994): 423-426. Available athttp://link.springer.com/article/10.1007/BF00201605#page-1 Data support a single mechanism of sequential nondisjunction during either maternal or paternal gametogenesis as the cause of higher order sex chromosome polysomy.
 * 6) "Polysomy". Retrieved 23 February 2014.<http://medical-dictionary.thefreedictionary.com/polysomy Medical Dictionary webpage includes 7 definitions of “Polysomy”.
 * Ma, Yan, et al. "Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practice." Clinical cancer research 11.12 (2005): 4393-4399. Available at http://clincancerres.aacrjournals.org/content/11/12/4393.short Researchers assessed the effect of chromosome 17 copy number on HER-2/neu status determination in breast cancers. Conclusion: A net increase in HER-2/neu gene copy number consecutive to polysomy 17 in the absence of specific gene amplification might lead to a strong protein overexpression in a small subset of breast carcinomas. HER-2/neu status determination by FISH is dependent on the criterion considered for positivity in clinical practice.
 * 1) Miller, John Adds, Erica Larkcom, Ruth (2004). Genetics, evolution and biodiversity (Rev. ed. ed.). Cheltenham: Nelson Thornes. ISBN 9780748774920.http://books.google.com/books Includes chapter on “Genes, alleles, and sources of new inherited variation”.
 * 2) Mossafa, H., et al. "Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis." Leukemia & lymphoma 47.9 (2006): 1885-1893. This study shows that some patients with non-Hodgkin's lymphoma (NHL) have abnormal chromosomes and eliminated a partial tri or polysomy of chromosome 8 being a factor.
 * Qu, L., and J. F. Hancock. "Detecting and mapping repulsion-phase linkage in polyploids with polysomic inheritance." Theoretical and Applied Genetics 103.1 (2001): 136-143 Available at Qu, L., and J. F. Hancock. "Detecting and mapping repulsion-phase linkage in polyploids with polysomic inheritance." Theoretical and Applied Genetics 103.1 (2001): 136-143. Available at http://link.springer.com/article/10.1007%2Fs001220100647?LI=true#page-1 Description of how mapping repulsion linkages can result in spurious results, and present methods to accurately detect the degree of preferential pairing in polyploids using repulsion linkage analysis.
 * 1) Reimann-Berg, N., et al. "Two new cases of polysomy 13 in canine prostate cancer." Cytogenetic and genome research 132.1-2 (2010): 16-21. This study revealed a rare polysomy, polysomy 13, in 2 dogs with prostate cancer and showed it is the only deviated karyotype known and is involved in the spontaneous development of prostate cancer and relate the similarities in the human chromosomes 8q & 4q and their role in generating tumors.
 * 2) "Is polysomy 17 an important phenomenon to predict treatment with trastuzumab in breast cancer?". Retrieved 23 February 2014.http://www.appliedcr.org.br/detalhe_artigo.asp?id=226 This study aimed to review the impact of polysomy 17 on HER2 testing and studied its clinicopathologic significance in relation to HER2 gene amplification and predicted treatment with trastuzumab.
 * Yeh, I., Martin, M., Robetorye, R., Bolla, A., McCaskill, C., Shah, P., Gorre, M., & Mohammed, M. (2009). Clinical validation of an array cgh test for her2 status in breast cancer reveals that polysomy 17 is a rare event. Modern Pathology, 22, 1169-1175. doi: 10.1038/modpathol.2009.78 Includes data that concludes that array comparative genomic hybridization is an accurate and objective DNA-based alternative for clinical evaluation of HER2 gene copy number, and that polysomy 17 is a rare event in breast cancer.
 * 1) S. Guijo, J. C., Mauricio, J. M. Salmon and J. M. Ortega. "Determination of the Relative Ploidy in Different Saccharomyces Cerevisiae Strains Used for Fermentation and ‘Flor’ Film Ageing of Dry Sherry-type Wines." Yeast 13.2 (1997): 101-17. Web. 25 Mar. 2014. The full chromosomal karyotype of six enological Saccharomyces cerevisiae strains used for fermentation and biological ageing of sherry-type wines was studied. In all strains examined, chromosome XIII polysomy is observed.

Possible Images

 * 1) http://biosearch.berkeley.edu/image.php?img=images%2Fopensearch%2Fartid%3D2040152%26blobname%3D1752-1947-1-94-2.jpg&pmid=17880714&fig=2
 * 2) http://biosearch.berkeley.edu/image.php?img=images%2Fopensearch%2Fartid%3D2040152%26blobname%3D1752-1947-1-94-1.jpg&pmid=17880714&fig=1
 * 3) http://biosearch.berkeley.edu/image.php?img=images%2Fopensearch%2Fartid%3D2266762%26blobname%3D1471-2407-8-3-1.jpg&pmid=18182111&fig=1
 * 4) http://biosearch.berkeley.edu/image.php?img=images%2Fopensearch%2Fartid%3D2432064%26blobname%3D1471-2407-8-169-1.jpg&pmid=18544172&fig=1
 * 5) http://biosearch.berkeley.edu/image.php?img=images%2Fopensearch%2Fartid%3D2576260%26blobname%3D1471-2164-9-489-2.jpg&pmid=18928532&fig=2